Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FVKCZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $94,335
Award facts
- Contract value 100% obligated
- $94,335.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded to AmerisourceBergen Drug Corp on August 5, 2025, procures 300 mg/2 mL Dupixent pens valued at $94,335.11 under a firm fixed-price arrangement with a completion date of August 6, 2025. The Defense Logistics Agency, which funds this award, is executing the order through AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This award carries no set-aside designation, indicating it was competitively awarded through open competition. Dupixent (dupilumab) is a biologic medication used to treat various inflammatory conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis, making it a specialized pharmaceutical product critical to military and federal healthcare systems.
This delivery order functions as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's established role as a major pharmaceutical distributor and DLA prime contractor demonstrates the company's capability to fulfill specialized federal medical procurement requirements, particularly for the Defense Health Agency and other government healthcare systems requiring expedited delivery of critical therapeutic medications.
Quick answers
Who was awarded contract SPE2DB25FVKCZ?
SPE2DB25FVKCZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FVKCZ worth?
The government has obligated $94,335 on SPE2DB25FVKCZ.
Is contract SPE2DB25FVKCZ an order under another contract?
Yes. SPE2DB25FVKCZ is a delivery order under SPE2DB25D3017, an indefinite delivery contract.
Was contract SPE2DB25FVKCZ competed?
The extent of competition for SPE2DB25FVKCZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award